Biotech Investors & VC Firms in New York
186 firms in this list, with a median first check of $500K. 50 of them lead rounds. Generated from verified public data and updated continuously.
SteelSky Ventures
AtlantaSeed$100K – $5M
11 people
Enterprise Investors Sp. z o. o.
WarsawSeries B–Growth$21.6M – $81M
27 people
Eckuity
CypressGrowth
24 people
Adverb Ventures
San FranciscoPre-Seed–Series A$500K – $5M
8 people
MBX Capital
ClaymontPre-Seed–Series A$250K – $2.5M
5 people
America's Frontier Fund
ArlingtonSeed–Growth$500K – $10M
13 people
Kinled Holding
Hong KongPre-Seed–Series A
1 person
SQ Capital
ZagrebPre-Seed–Series A
12 people
MC Healthcare Ventures
CambridgeSeed–Series A
6 people
Helm
New York CityPre-Seed–Series A$500K
4 people
Tetragon Financial Group Limited
LondonSeries C
15 people
Logos
San FranciscoSeries A–Series B
15 people
Helios Capital
South FloridaPre-Seed–Series A$25K – $1M
2 people
NYBC Ventures
BostonSeed–Series B
9 people
Petri
BostonPre-Seed$100K – $6M
6 people
Braidwell
StamfordSeed–Late Stage
9 people
PFM Health Sciences
San Francisco
9 people
47 Ventures
EbenePre-Seed–Series A$150K – $2M
1 person
Related lists
Investors & VC Firms in North America (13326)Investors & VC Firms in United States (12318)Investors & VC Firms in Europe (6083)AI & Machine Learning Investors & VC Firms (5352)Investors & VC Firms in Global (5318)Fintech Investors & VC Firms (5140)Healthtech Investors & VC Firms (4657)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4424)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.
































































